Bishops urge EU not to fund embryonic stem-cell research
December 16, 2011
The Commission of the Bishops’ Conferences of the European Community is urging the European Union not to fund embryonic stem-cell research in Horizon 2020, its $104-billion research program for 2014 to 2020.
“Recently, Geron Corp., the world’s leading embryo research company, announced it was closing down its stem cell program,” COMECE stated. “As a matter of fact, human embryonic stem cell research has not delivered the expected results. In the meantime, research on alternative sources of stem cells--adult, umbilical cord blood or induced pluripotent--offer real, effective prospects for therapeutic applications or have indeed already demonstrated widespread clinical results.”
“These methods, because they enjoy wide acceptance--both on scientific and ethical grounds--are not controversial among member states. They should therefore be prioritized in the context of EU funding.”
For all current news, visit our News home page.
Further information:
All comments are moderated. To lighten our editing burden, only current donors are allowed to Sound Off. If you are a current donor, log in to see the comment form; otherwise please support our work, and Sound Off!
